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Questionnaire; completed by participants ages 40 – 80. After exclusion of persons 
with negative sample weights and missing data, the final sample was 3437. Chi-
square and ANOVA were used to make statistical comparisons and all analyses 
were weighted to account for the sampling design. Results: The prevalence of 
taste dysfunction was 5.3% (95% CI 4.6, 6.1). Taste dysfunction was higher in older 
adults compared to younger adults (6.9% and 4.2%, respectively, p < .01), and in 
those reporting problems with smell compared to those with no problem (21.2% and 
3.4%, respectively, p < .0001). Persons with taste dysfunction reported significantly 
more days of poor physical health (mean = 6.4, SE = 1.1) and mental health (mean 
= 6.2, SE = 1.1) than those without problems with taste mean = 3.9, SE = .24, p = .04; 
mean = 3.7, SE = 0.24, p = .03, respectively). ConClusions: Based on self-reported 
data, taste dysfunction affects 5% of the weighted sample. Discrepancies between 
reported prevalence from 1994 are likely due to differences in the operationaliza-
tion of taste dysfunction. The association of problems with taste and the increase 
in reported days of poor physical and mental health should be investigated further.
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objeCtives: Drugs with anticholinergic properties are associated with central and 
peripheral adverse effects in the elderly. The purpose of this study was to deter-
mine the prevalence and predictors of inappropriate anticholinergic medication 
use among the elderly as per 2012 American Geriatrics Society (AGS) Beers’ crite-
ria. Methods: A retrospective cross-sectional study design was conducted using 
2009-2010 Medical Expenditure Panel Survey (MEPS). The study sample included 
individuals aged ≥ 65 years. Inappropriate anticholinergic drugs were identified 
using the MEPS prescription files. Weighted descriptive statistics were used to esti-
mate the prevalence of inappropriate anticholinergic medication use in elderly 
patients. Multivariable logistic regression within the conceptual framework of 
Anderson Behavioral Model was used to identify predictors associated with the 
use of inappropriate anticholinergic medications in the elderly. Results: Analysis 
of the 2009-2010 MEPS data revealed that an estimated 78.6 million members of 
the US population were elderly. (12.78%) It was estimated that 7.51 million (95% CI: 
6.64 to 8.38) of elderly individuals used potentially inappropriate anticholinergic 
medications, resulting in an overall prevalence of 9.56%. The most frequently used 
inappropriate anticholinergics were cyclobenzaprine (2.08%), promethazine (1.75%), 
amitriptyline (1.47%), hydroxyzine (0.95%), and dicyclomine (0.84%). Multivariable 
analyses revealed that female gender (OR: 1.37; 95% CI: 1.06-1.77), South region (OR: 
1.88; 95% CI: 1.25-2.84) and anxiety disorder (OR: 2.15; 95% CI: 1.57-2.94) increased 
the likelihood of receiving inappropriate anticholinergic medications; whereas age 
between 75 to 84 years (OR: 0.64; 95% CI: 0.49-0.85), age > = 85 years (OR: 0.52; 95% 
CI: 0.33-0.81) and > 15 years of education (OR: 0.54; 95% CI: 0.35-0.84) decreased the 
likelihood of receiving inappropriate anticholinergic medications. ConClusions: 
The study found that approximately one in ten elderly patients used inappropriate 
anticholinergic medications. Several predisposing and need factors were associ-
ated with the use of inappropriate anticholinergic medications. Efforts are needed 
to improve inappropriate prescribing practices to optimize medication use in the 
elderly.
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objeCtives: Health care risk epidemiology identifies medication error as the 
commonest cause of adverse effects on patients. Errors can occur at any phase of 
the medication process, so incidence rates should be estimated along with their 
clinical outcomes at each stage. The aim of this study was to assess and analyze 
the medication errors for determining their nature, types, incidence and clinical 
significance in an Indian setting. Methods: This prospective observational study 
was conducted in 3 medical wards of a public teaching hospital. All the information 
was collected in a standard data collection form. Medication errors were identified 
and analyzed from patients’ records using Current Index of Medical Sciences (CIMS) 
and Micromedex Drug-Reax database. Results: Of the 450 studied, 87 patients 
were found to have 113 medication errors. The 3 most common errors were drug 
interactions followed by inappropriate frequency and overdose (35%, 23% and 8%, 
respectively). Other errors were underdose, incomplete prescription and duplication 
of therapy. Nitrofurantoin, domperidone & cefixime were common drugs admin-
istered at inappropriate frequency. Drugs involved in overdose were enoxaparin, 
gentamicin, azithromycin & domperidone. The incidence of medication error was 
26%. Antimicrobial agents (34%) had contributed maximum to the error followed 
by GI agents (20%), anticoagulants (11%) and CNS agents (8%). All the errors were 
category B error (NCC MERP medication error index) ConClusions: The avail-
ability of such evidence will help in improving patient safety in Indian setting and 
to promote medication safety.
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objeCtives: Causality assessment is the evaluation of the likelihood that a particu-
lar treatment is the cause of an observed adverse event. The aim of this study was to 
ication, which increased to 53.2% by 5 years. Overall, ADHD drug use was most com-
mon in patients aged 1-5 and 6-12 years whereas antipsychotics were most common 
in adolescents (13-17 years) and young adults (18-25 years). The effects of age group 
on the use of the different drug classes were statistically significant (p< 0.0001). We 
observed significant changes in drug use over time for all psychoactive drug classes 
(either increase or decrease), except for anxiolytics. ConClusions: Psychoactive 
medication use increased over the 5-year period among newly diagnosed ASD peo-
ple, whatever the age group. Optimal use of these medications in the context of 
limited access to other types of support modalities is discussed.
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objeCtives: The objective of this study was to determine if long-acting reversible 
contraception (LARC) use prior to pregnancy and health plan type were associated 
with greater likelihood of having an intended pregnancy (IP). Methods: Women 
members of the Kaiser Permanente, Northern California (KPNC) integrated health 
plan aged 15-44 years who became pregnant between 1/1/2010 and 12/31/2012 were 
identified from KPNC databases. The last contraceptive method used within 2 years 
preceding pregnancy was determined. Key characteristics were compared among 
women with IPs vs. those with unintended pregnancies (UPs-unwanted or mis-
timed). Logistic regression analyses were conducted to determine if health plan 
type, copays or prior LARC use were predictive of IP, controlling for age, race/ethnic-
ity, marital status, education/income, parity, and select comorbidities. Results: 
Among women included in the study, 27,498 (61%) had IPs and 17,853 (39%) had 
UPs. Higher education (47.9% vs. 17.2%), an income ≥ $60,000 (55.0% vs. 21.0%), 
and already having one child (39.0% vs. 21.3%) were significantly (p< 0.0001) more 
common among women with IPs. In comparison to women with IPs, significantly 
(p< 0.0001) larger proportions of women with UPs were ≤ 24 years old (33.7% vs. 
6.5%), single (39.8% vs. 5.5%), and had evidence of comorbidities (7.72% vs. 7.12%). 
When controlling for key characteristics, women who used LARC methods prior to 
pregnancy vs. women using non-LARC methods were 2.3-fold (p< 0.0001) more likely 
to have an IP. Women with deductible plans with health savings accounts (HSA) vs. 
those with non-deductible plans had greater odds of having an IP (1.16, p= 0.01). 
Upon further stratified analysis, prior use of LARC methods was associated with 
significantly greater likelihoods of having an IP across all evaluated race/ethnicities 
and education/incomes levels. ConClusions: Women KPNC members who used 
LARC methods prior to pregnancy and those who had a HSA were more likely to 
have an IP than an UP.
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objeCtives: The current study examined patient age, gender, race, geographic 
variation as well as the prevalence of autism in children using U.S. Medicaid 
data. Methods: A retrospective study was performed among the Medicaid fee-for-
service (FFS) population from January 1, 2008 through December 31, 2009. Children 
under age 17 years and diagnosed with autism were identified using International 
Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) diagnosis 
code 299.0x. A 2-year period of continuous Medicaid FFS enrollment during the 
study period was required. Disease prevalence was stratified by region, state, age, 
gender and race for all patients, and measured by number and percentage in each 
category. Patients with managed care enrollment in any month of 2008 or 2009 
were excluded from the study. Results: A total of 23,589 children diagnosed with 
autism were analyzed. Children age 6-10 years had the highest autism prevalence 
level (4.59%), followed by those age 11-17 (3.62%) and 0-5 years (1.50%). Prevalence 
results according to race are as follows: Asian (6.33%), White (4.06%), Hispanic (3.29%) 
and Black (2.75%). Autism was more likely to be diagnosed among boys (5.01%) than 
girls (1.62%). Geographic variation analysis showed the highest autism prevalence 
in Idaho (34.06%), followed by Oklahoma (17.14%), Connecticut (14.05%), Minnesota 
(13.44%) and Rhode Island (11.33%). The Southern region of the United States was 
found to have the highest autism prevalence for children under age 17 (4.35%), com-
pared to the Midwest (4.03%), Northeast (3.43%) and West (0.82%). ConClusions: 
Children age 6-10 years had a higher probability of being diagnosed with autism, 
with Asian patients most likely to be diagnosed with autism compared to other 
races. Children residing in the Midwestern region of the United States were shown 
to be at a higher risk for an autism diagnosis.
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objeCtives: There are no current nationally representative estimates on taste 
dysfunction for the US population; the last estimates based on the 1994 National 
Health Interview Study indicated population prevalence reports of taste problems 
of 0.6%. The purpose of this study is to provide current estimates of the preva-
lence of taste dysfunction and identify the relationship between taste dysfunction 
and health perception in the US population. Methods: Data from the 2011-2012 
National Health and Nutrition Examination Survey (NHANES) was used to assess 
the prevalence of self-reported taste dysfunction as assessed by the Taste and Smell 
